冶成梅,杨勇莉

本研究聚焦高原地区多囊卵巢综合症，分析其在特殊地理环境影响下的临床特点，并探讨针对性治疗方法。通过回顾性研究分析，发现高原地区PCOS患者在代谢紊乱、生殖功能异常及心理状态等方面表现出与平原地区的差异，结合高原环境因素提出综合治疗方案，为优化该地区PCOS患者的诊疗提供理论依据。

高原地区；多囊卵巢综合症；临床特点；治疗方法

[1] Yan L W,Kan Q Z,Wang Q L,et al.Comparative effectiveness and safety of acupuncture vs metformin in insulin-resistant polycystic ovary syndrome women:A network meta-analysis of RCTs[J].Integrative Medicine Research,2025,14(2):101148-101148. [2] Hai B,Zhang Y,Huang J,et al.Exploring the key ingredients and mechanisms of Banxia Xiexin decoction for the treatment of polycystic ovary syndrome based on network pharmacology and experimental validation.[J].Annals of medicine,2025,57(1):2503921. [3] Pirim D,BağcıA F.Dissecting the shared molecular mechanisms underlying polycystic ovary syndrome and schizophrenia etiology:a translational integrative approach.[J].Systems biology in reproductive medicine,2025,71(1):11-12. [4] Rittig N,Søborg A C M,Svart V M,et al.Ketone supplementation acutely lowers androgen and glucose levels in women with polycystic ovary syndrome(PCOS):A randomised clinical trial.[J].European journal of endocrinology,2025, [5] Morsy A A,Sabri A N,Mourad M A,et al.New insights into pentoxifylline andα-lipoic acid:Co-administration with clomiphene citrate for ovulation induction in anovulatory women with polycystic ovary syndrome.[J].Clinical and experimental reproductive medicine,2025, [6]Cannarella R,Rubulotta M,Leonardi A,et al.Effects of ketogenic diets on polycystic ovary syndrome:a systematic review and meta-analysis[J].Reproductive Biology and Endocrinology,2025,23(1):74-74. [7] Lin T,Xie B,Yang J,et al.Changes in the global burden of polycystic ovary syndrome from 1990 to 2021[J].Reproductive Health, 2025,22(1):86-86. [8] Mohammed G Z,Farman A H.Epiregulin dysregulation in polycystic ovary syndrome:metabolic and ovarian implications[J].Middle East Fertility Society Journal,2025,30(1):15-15. [9] Yan X,Yang Z,Zhao H,et al.Unveiling lipoprotein subfractions signature in high-FNPO PCOS:implications for PCOM diagnosis and risk assessment using advanced machine learning models[J].BMC Medicine,2025,23(1):289-289. [10] Hu S,Bester L S,Salem J,et al.Validity of administrative health data case definitions for identifying polycystic ovary syndrome:a systematic review and meta-analysis.[J].Human reproduction(Oxford,England),2025, [11] Chen X,Xiao Z,Cai Y,et al.Reproductive hormone characteristics of obese Chinese patients with polycystic ovarian syndrome:a meta-analysis.[J].Gynecological endocrinology:the official journal of the International Society of Gynecological Endocrinology,2025, 41(1):2497854. [12] Salem B A,Ezzidi I,Abdennebi B H,et al.A novel link between KCNQ1 genetic variants and polycystic ovary syndrome susceptibility.[J].Biomedical reports,2025,22(6):104. [13] Bree V E B,Heijden D V B M D,Golde V T J R,et al.Sex hormone-binding globulin as a biomarker for metabolic risk in European women with polycystic ovary syndrome.[J].Gynecological endocrinology:the official journal of the International Society of Gynecological Endocrinology,2025,41(1):2500462. [14] Olabisi F J F,Oyerinde R O,Faokunla O O,et al.Alpha-lipoic acid regulates pro-inflammatory cytokines and hormones in letrozole- induced polycystic ovary syndrome in rats[J].Endocrine and Metabolic Science,2025,18 100245-100245. [15] Waldrop W S,Buenaventura M,Reyes C J K,et al.Disparities in the Diagnosis and Management of Polycystic Ovarian Syndrome in Adolescents.[J].Endocrinology and metabolism clinics of North America,2025,54(2):233-250. [16] Huang X,Chen J,Yu Y,et al.The impact of polycyclic aromatic hydrocarbon metabolites on reproductive hormone levels and follicle count in patients with polycystic ovary syndrome:a case-control study.[J].International journal of environmental health research, 2025,11-12. [17] Kahn G L,Hipwell E A,Charifson M,et al.Maternal polycystic ovarian syndrome and offspring psychopathology and neurodevelo- pment.[J].Human reproduction(Oxford,England),2025, [18] Tang Z W,Cai Y Q,Huang J K,et al.The global burden of polycystic ovary syndrome,endometriosis,uterine fibroids,cervical cancer,uterine cancer,and ovarian cancer from 1990 to 2021[J].BMC Public Health,2025,25(1):1774-1774. [19] Wang L,Jin Y,Zhi Y,et al.Effects of melatonin in polycystic ovary syndrome:is there Hippo pathway crosstalk?[J].Journal of Ovarian Research,2025,18(1):101-101. [20] Heidari R,Eftekhari F,Jahromi K M.Association of physical activity and nutrition-related knowledge,attitudes and practices with obesity indices in college-aged females with polycystic ovary syndrome in Shiraz,Iran:a cross-sectional study.[J].BMJ open,2025, 15(5):e099260. [21] 苏婷,张靖,邵华,等.朱颖教授运用周期疗法治疗多囊卵巢综合征经验[J].陕西中医药大学学报,2024,47(02):115-118. [22] 彭伶.桂枝茯苓胶囊辅助治疗多囊卵巢综合症患者的临床效果及安全性评价[J].现代诊断与治疗,2024,35(05):653-655. [23] 刘艳美.多囊卵巢综合症患者咋备孕[N].甘肃科技报,2024-03-06(005). [24] 李嘉鑫.肥胖型多囊卵巢综合征不孕患者自我管理需求量表的编制及信效度检验[D].长江大学,2024. [25] 张雅.多囊卵巢综合征患者中医慢病管理方案的构建[D].安徽中医药大学,2024. [26] 乔炳翔.基于PI3K/AKT通路探讨助阳化湿法对PCOS合并胰岛素抵抗的作用机制[D].辽宁中医药大学,2024. [27] 王鑫.卵泡液有害金属元素暴露与多囊卵巢综合征发生风险的关联研究[D].安徽医科大学,2024. [28] 李金美.关于月经不调你想知道的答案都在这里[N].山西科技报,2023-12-28(B03). [29] 陈建辉.肾气丸治疗肾阳虚型PCOS不孕症的临床疗效与网络药理学研究[D].广州中医药大学,2023. [30] 袁媛,赵咏梅.来曲唑联合二甲双胍片对多囊卵巢综合症合并不孕症患者性激素及妊娠结局的影响研究[C]//广东省肿瘤康复学会.2023年华南康复医学与护理研究学术会议论文集.宣城市中心医院;,2023:255-258. [31] 金甫暻.基于数据挖掘法分析中医药治疗PCOS高雄激素血症的用药规律[D].北京中医药大学,2023. [32] 李海明.认识多囊卵巢综合征[J].人人健康,2023,(26):40-41.

点击下载PDF